Caxton Associates (UK)’s Artivion AORT Stock Holding History

Caxton Associates (UK)’s Portfolio AORT Stock Details AORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6,458	Closed	-$295K	–	774
2025 Q4	$295K	Buy	+6,458	New	+$288K	0.01%	625

Other funds holding AORT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

JIC

Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Caxton Associates (UK)'s AORT Position: Q1 2026 in Review

Caxton Associates (UK) sold out of Artivion (AORT) in Q1 2026, closing a stake of 6,458 shares — an estimated $295K sold.

Caxton Associates (UK) first reported a position in AORT in Q4 2025 and held it in 1 quarter. The position peaked at $295K in Q4 2025. 239 funds tracked by Wall St. Rank hold AORT as of Q1 2026.

Caxton Associates (UK) reported no remaining Artivion position as of Q1 2026 after selling out during the quarter.
Caxton Associates (UK) sold 6,458 Artivion shares in Q1 2026, an estimated $295K.
Caxton Associates (UK) first reported a position in Artivion in Q4 2025 and held it in 1 quarter.
Caxton Associates (UK)'s Artivion position peaked at $295K in Q4 2025.
239 funds tracked by Wall St. Rank held Artivion as of Q1 2026.

Based on Caxton Associates (UK)'s 13F filing for Q1 2026, filed 14 May 2026.